Copyright © 1986 by the European Society of Cardiology.
© 1986 The European Society of Cardiology
The multifactor primary prevention trial in Göteborg, Sweden
Department of Medicine, University of Göteborg, Östra Hospital 416 85 Göteborg, Sweden
Received 28 October 1985; revised 27 December 1985; .
Address for correspondence: Lars Wilhelmsen, M.D., Department of Medicine, Östra Hospital, S-416 85 Göteborg, Sweden
Abstract
The effect of a multifactorial intervention programme on coronary heart disease (CHD), stroke incidence and total mortality was determined in a random sample of men, 47–55 years old at entry. The intervention group comprised 10004 men, and the two control groups were of similar size. The intervention consisted of antihypertensive treatment in subjects with screening blood pressure above 175 mmHg systolic or 115 mmHg diastolic, dietary advice to men with serum cholesterol levels above 260 mg per 100 ml ( = 6.8 mMol l–1), advice to stop smoking to subjects who smoked more than 15 cigarettes per day. The intervention was applied for 10 years during which time CHD and stroke incidence and mortality were followed by means of special registers. Participation rate at first screening examination was 75%.
Key Words: Coronary heart disease • stroke • prevention • risk factors • hypertension • smoking • serum cholesterol
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Ahmadi-Kashani, D. J. Kessler, J. Day, T. J. Bunch, K. Q. Stolen, S. Brown, S. Sbaity, B. Olshansky, and on behalf of the INTRINSIC RV Study Investigators Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population Circulation, November 24, 2009; 120(21): 2040 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosengren, P. J. Hauptman, G. Lappas, L. Olsson, L. Wilhelmsen, and K. Swedberg Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men Eur. Heart J., May 1, 2009; 30(9): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. LAUER Autonomic function and prognosis Cleveland Clinic Journal of Medicine, April 1, 2009; 76(Suppl_2): S18 - S22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lauritzen, M. S. Ager Jensen, J. L. Thomsen, B. Christensen, and M. Engberg Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs: An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP) Scand J Public Health, August 1, 2008; 36(6): 650 - 661. [Abstract] [PDF]
|
|
|
|
 |
|
 U. N. Toft, L. H. Kristoffersen, M. Aadahl, L. von Huth Smith, C. Pisinger, and T. Jorgensen Diet and exercise intervention in a general population mediators of participation and adherence: the Inter99 study Eur J Public Health, October 1, 2007; 17(5): 455 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schaufelberger and A. Rosengren Heart failure in different occupational classes in Sweden Eur. Heart J., January 2, 2007; 28(2): 212 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Harmsen, G. Lappas, A. Rosengren, and L. Wilhelmsen Long-Term Risk Factors for Stroke: Twenty-Eight Years of Follow-Up of 7457 Middle-Aged Men in Goteborg, Sweden Stroke, July 1, 2006; 37(7): 1663 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Thomsen, B. Karlsmose, E. T. Parner, A. M. Thulstrup, T. Lauritzen, and M. Engberg Secondary healthcare contacts after multiphasic preventive health screening: A randomized trial Scand J Public Health, May 1, 2006; 34(3): 254 - 261. [Abstract] [PDF]
|
|
|
|
|
|
P. Eriksson, L. Wilhelmsen, and A. Rosengren Bundle-branch block in middle-aged men: risk of complications and death over 28 years: The Primary Prevention Study in Goteborg, Sweden Eur. Heart J., November 1, 2005; 26(21): 2300 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wilhelmsen, M. Koster, P. Harmsen, and G. Lappas Differences between coronary disease and stroke in incidence, case fatality, and risk factors, but few differences in risk factors for fatal and non-fatal events Eur. Heart J., September 2, 2005; 26(18): 1916 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosengren, I. Skoog, D. Gustafson, and L. Wilhelmsen Body Mass Index, Other Cardiovascular Risk Factors, and Hospitalization for Dementia Arch Intern Med, February 14, 2005; 165(3): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jood, C. Jern, L. Wilhelmsen, and A. Rosengren Body Mass Index in Mid-Life Is Associated With a First Stroke in Men: A Prospective Population Study Over 28 Years Stroke, December 1, 2004; 35(12): 2764 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.N. Singh Increased heart rate as a risk factor for cardiovascular disease Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G3 - G9. [Abstract] [PDF]
|
|
|
|
|
|
J.P. Vilaine, C. Thollon, N. Villenueve, and J.L. Peglion Procoralan, a new selective If current inhibitor Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G26 - G35. [Abstract] [PDF]
|
|
|
|
|
|
R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J., June 1, 2003; 24(11): 987 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Blake, P. M. Ridker, and K. M. Kuntz Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels J. Am. Coll. Cardiol., July 3, 2002; 40(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singh Diabetes, Heart Rate, and Mortality Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 117 - 129. [Abstract] [PDF]
|
|
|
|
|
|
B. N. Singh Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 313 - 331. [PDF]
|
|
|
|
|
|
A Rosengren, A Dotevall, H Eriksson, and L Wilhelmsen Optimal risk factors in the population: prognosis, prevalence, and secular trends. Data from Goteborg population studies Eur. Heart J., January 2, 2001; 22(2): 136 - 144. [Abstract] [PDF]
|
|
|
|
|
|
C. Eriksson Review Article: Learning and knowledge-production for public health: a review of approaches to evidence-based public health Scand J Public Health, October 1, 2000; 28(4): 298 - 308. [Abstract] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, C. C. Sigman, K. M. Johnson, C. W. Boone, P. Greenwald, J. A. Crowell, E. T. Hawk, and L. A. Doody Perspectives on Surrogate End Points in the Development of Drugs that Reduce the Risk of Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 127 - 137. [Abstract] [Full Text]
|
|
|
|
|
|
A. Rosengren, H. Wedel, and L. Wilhelmsen Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality: A prospective population study Eur. Heart J., February 2, 1999; 20(4): 269 - 277. [Abstract] [PDF]
|
|
|
|
 |
|
 H. C. Bucher, L. E. Griffith, and G. H. Guyatt Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 187 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Agewall, J. Wikstrand, and B. Fagerberg Stroke Was Predicted by Dimensions of Quality of Life in Treated Hypertensive Men Stroke, November 1, 1998; 29(11): 2329 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. K Andersson, T. Almgren, B. Persson, O. Samuelsson, T. Hedner, and L. Wilhelmsen Survival in treated hypertension: follow up study after two decades BMJ, July 18, 1998; 317(7152): 167 - 171. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Gould, J. E. Rossouw, N. C. Santanello, J. F. Heyse, and C. D. Furberg Cholesterol Reduction Yields Clinical Benefit : Impact of Statin Trials Circulation, March 17, 1998; 97(10): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Fager and O. Wiklund Cholesterol Reduction and Clinical Benefit : Are There Limits to Our Expectations? Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3527 - 3533. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. D. M. Pyke, D. A. Wood, K. Ann-Louise, and S. G. Thompson Change in Coronary Risk and Coronary Risk Factor Levels in Couples Following Lifestyle Intervention: The British Family Heart Study Arch Fam Med, July 1, 1997; 6(4): 354 - 360. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Agewall and B. Fagerberg Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men Angiology, October 1, 1996; 47(10): 963 - 972. [Abstract] [PDF]
|
|
|
|
|
|
Mortality After 16 Years for Participants Randomized to the Multiple Risk Factor Intervention Trial Circulation, September 1, 1996; 94(5): 946 - 951. [Abstract] [Full Text]
|
|
|
|
|
|
M. Suurkula, B. Fagerberg, I. Wendelhag, S. Agewall, and J. Wikstrand Atherosclerotic Disease in the Femoral Artery in Hypertensive Patients at High Cardiovascular Risk: The Value of Ultrasonographic Assessment of Intima-Media Thickness and Plaque Occurrence Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 971 - 977. [Abstract] [Full Text]
|
|
|
|
|
|
M. Suurkula, S. Agewall, B. Fagerberg, I. Wendelhag, and J. Wikstrand Multiple Risk Intervention in High-Risk Hypertensive Patients : A 3-Year Ultrasound Study of Intima-Media Thickness and Plaques in the Carotid Artery Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 462 - 470. [Abstract] [Full Text]
|
|
|
|
|
|
S. Agewall, B. Fagerberg, S. Attvall, I. Wendelhag, V. Urbanavicius, and J. Wikstrand Carotid Artery Wall Intima-Media Thickness Is Associated With Insulin-Mediated Glucose Disposal in Men at High and Low Coronary Risk Stroke, June 1, 1995; 26(6): 956 - 960. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Gould, J. E. Rossouw, N. C. Santanello, J. F. Heyse, and C. D. Furberg Cholesterol Reduction Yields Clinical Benefit : A New Look at Old Data Circulation, April 15, 1995; 91(8): 2274 - 2282. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Denke Cholesterol-Lowering Diets: A Review of the Evidence Arch Intern Med, January 9, 1995; 155(1): 17 - 26. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Samuelsson, L. Wilhelmsen, O. K. Andersson, K. Pennert, and G. Berglund Cardiovascular Morbidity in Relation to Change in Blood Pressure and Serum Cholesterol Levels in Treated Hypertension: Results From the Primary Prevention Trial in Goteborg, Sweden JAMA, October 2, 1987; 258(13): 1768 - 1776. [Abstract] [PDF]
|
|